help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on May 1, 2003, doi:10.1165/rcmb.2002-0044OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-0044OCv1
29/4/513    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waxman, A. B.
Right arrow Articles by Elias, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waxman, A. B.
Right arrow Articles by Elias, J. A.
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 513-522, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2002-0044OC

Interleukin-11 and Interleukin-6 Protect Cultured Human Endothelial Cells from H2O2-Induced Cell Death

Aaron B. Waxman, Keyvan Mahboubi, Roy G. Knickelbein, Lin L. Mantell, Nicholas Manzo, Jordan S. Pober and Jack A. Elias

Pulmonary Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts; Interdepartmental Program in Vascular Biology and Transplantation, Boyer Center for Molecular Medicine, Yale University School of Medicine; Department of Pediatrics, Yale University School of Medicine, Department of Internal Medicine, New Haven, Connecticut; Cardiac Research Laboratory, Department of Surgery, North Shore-Long Island Jewish Medical Center, New York University School of Medicine, Manhasset, New York; and Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, Department of Internal Medicine, New Haven, Connecticut

Address correspondence to: Aaron B. Waxman, Pulmonary Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Bulfinch 148 Boston, MA 02114. E-mail: ABWaxman{at}Partners.org

Acute lung injury is a frequent and treatment-limiting consequence of therapy with 100% oxygen. Previous studies have determined that both interleukin (IL)-6 and IL-11 are protective in oxygen toxicity. This protection was associated with markedly diminished alveolar–capillary protein leak, endothelial and epithelial membrane injury, lipid peroxidation, and pulmonary neutrophil recruitment. Hyperoxia also caused cell death with DNA fragmentation in the lungs of transgene (-) animals, and both IL-6 and IL-11 markedly diminished this cell death response. However, the mechanism(s) by which these cytokines protect cells from death is unclear. In the present study, we characterized the effects of H2O2 on subconfluent human umbilical vein endothelial cell (HUVEC) and human pulmonary microvascular endothelial cell (HPMEC) cultures. We found that preincubation of HUVEC cultures with either IL-6 or IL-11 diminished H2O2 (1.0 mM)-induced cell death. Similar effects were noted with HPMEC showing that this effect is not HUVEC-specific. The protective effects of both IL-6 and IL-11 were not associated with any changes in antioxidants and were decreased by ~ 80% in the presence of U0126, a specific inhibitor of MEK-1–dependent pathways. The cytoprotective effects of IL-11 and IL-6 were also completely eliminated in STAT3 dominant-negative transduced HUVEC cultures. These studies demonstrate that IL-6 and IL-11 both confer cytoprotective effects that diminish oxidant-mediated endothelial cell injury. They also demonstrate that this protection is mediated, at least in part, by a STAT3 and MEK-1–dependent specific signal transduction pathway(s).

Abbreviations: human pulmonary microvascular endothelial cell(s), HPMEC • horseradish peroxidase, HRP • human umbilical vein endothelial cell(s), HUVEC • interleukin, IL • polyacrylamide gel electrophoresis, PAGE • phosphate-buffered saline, PBS • sodium dodecyl sulfate, SDS • superoxide dismutase, SOD




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. B. Waxman and N. Kolliputi
IL-6 Protects against Hyperoxia-Induced Mitochondrial Damage via Bcl-2-Induced Bak Interactions with Mitofusions
Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 385 - 396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Mack, R. S. BelAiba, T. Djordjevic, A. Gorlach, H. Hauner, and B. L. Bader
Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNF{alpha} exposure
Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E735 - E748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Kolliputi and A. B. Waxman
IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation
Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L6 - L16.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Kolliputi and A. B. Waxman
IL-6 Cytoprotection in Hyperoxic Acute Lung Injury Occurs via Suppressor of Cytokine Signaling-1-Induced Apoptosis Signal-Regulating Kinase-1 Degradation
Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 314 - 324.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. K. Steiner, O. L. Syrkina, N. Kolliputi, E. J. Mark, C. A. Hales, and A. B. Waxman
Interleukin-6 Overexpression Induces Pulmonary Hypertension
Circ. Res., January 30, 2009; 104(2): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Choo-Wing, J. H. Nedrelow, R. J. Homer, J. A. Elias, and V. Bhandari
Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L142 - L150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. G. d. Paz, S. Simeonidis, C. Leo, D. W. Rose, and T. Collins
Regulation of NF-{kappa}B-dependent Gene Expression by the POU Domain Transcription Factor Oct-1
J. Biol. Chem., March 16, 2007; 282(11): 8424 - 8434.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. O Huising, C. P Kruiswijk, and G. Flik
Phylogeny and evolution of class-I helical cytokines.
J. Endocrinol., April 1, 2006; 189(1): 1 - 25.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Mechoulam and E. A. Pierce
Expression and Activation of STAT3 in Ischemia-Induced Retinopathy
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4409 - 4416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Rochman, W. E. Paul, and S. Z. Ben-Sasson
IL-6 Increases Primed Cell Expansion and Survival
J. Immunol., April 15, 2005; 174(8): 4761 - 4767.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Torpey, S. E. Maher, A. L. M. Bothwell, and J. S. Pober
Interferon {alpha} but Not Interleukin 12 Activates STAT4 Signaling in Human Vascular Endothelial Cells
J. Biol. Chem., June 18, 2004; 279(25): 26789 - 26796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ahmad, A. Ahmad, M. Ghosh, C. C. Leslie, and C. W. White
Extracellular ATP-mediated Signaling for Survival in Hyperoxia-induced Oxidative Stress
J. Biol. Chem., April 16, 2004; 279(16): 16317 - 16325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society.
  Red In Translatin